Compare Eni SpA (E) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs Tenet Healthcare Corporation — how do they compare? Eni SpA trades at $48.11 (market cap $70.34B), while Tenet Healthcare Corporation trades at $200 (market cap $16.57B). The key difference: Eni SpA is far larger — about 4.2× Tenet Healthcare Corporation's market cap, and Eni SpA pays a 4.99% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| E | THC | |
|---|---|---|
Market Cap | $70.34B | $16.57B |
Sector | Energy | Health |
52-Week High | $57.61 | $244.80 |
52-Week Low | $32.93 | $148.38 |
Enterprise Value | $89.25B | $26.81B |
Dividend Yield | 4.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $49.55, up 0.22% with a bullish technical signal supported by moving averages. The company shows stable cash flow generation with $238M net cash flow in 2025 and maintains a dividend of $0.63. Recent strategic expansions into renewable fuels, lithium, and energy trading through partnerships with BMW, Mercuria, and UKAEA highlight diversification efforts. Valuation metrics appear reasonable with P/E of 21.6 and EV/EBITDA of 3.83, though revenue has declined from $132.5B in 2022 to $82.15B in 2025.
The outlook balances strategic growth initiatives against revenue pressures. Opportunities exist in energy transition projects and trading expansion, but risks include oil price volatility and execution challenges. Analyst sentiment is mixed with 34.6% buy ratings versus 61.5% hold, suggesting cautious optimism. The stock's investment case hinges on successful diversification while managing core energy market exposure.
Tenet Healthcare (THC) trades at $199.10, up 8.39% over the past day, with strong fundamental metrics including a P/E of 10 and net income margin of 7.79%. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 EPS of $4.82 surpassing the $4.17 estimate. Technical indicators show a bearish trend with support at $187 and resistance at $197, while analyst sentiment remains overwhelmingly positive with 26 buy ratings and a consensus price target of $235.88.
The outlook for THC is favorable due to robust earnings performance and attractive valuation, though near-term price volatility and competitive pressures in healthcare pose risks. Revenue growth is projected to increase from $21.3B in 2025 to $21.9B in 2026, supporting further upside if execution continues. Investors should monitor Q2 2026 earnings due July 24, 2026, for confirmation of growth trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
